May 31, 2019
WORLD NO TOBACCO DAY Every year, 31st May is observed as World Tobacco Day. This day is intended to spread awareness about health issues associated with tobacco use and to encourage the government to adopt effective policies to reduce the use of tobacco products. Every year, approximately 7 million people die du...
Read More...
Oct 30, 2024
Neuroendocrine tumors (NET) begin in the neuroendocrine system of the body, developing in cells that interact with neurons and hormone-producing cells. These cells can be found throughout the body, but most often in the abdomen, particularly in the gastrointestinal tract. The tumor can also develop in the lungs, pa...
Read More...
May 30, 2019
Iovance infuses USD 75 M to boost Cancer therapy Iovance Biotherapeutics is all set to build a 136,000-square-foot facility in Philadelphia to develop cancer therapies using its tumour-infiltrating lymphocyte (TIL) technology. Building the new facility will cost the Iovance around USD 75 Million. The biotherapeu...
Read More...
May 29, 2019
Before you all start to panic, let us establish one thing first that it is crucial to understand the rising causes behind the rates of Autism and find a solution for it. Every dis-ease or discomfort that affects a human body in any way is without a doubt, a cause of concern. So it is necessary to address it in the ...
Read More...
May 28, 2019
Stem cells can regenerate heart Researchers at the Icahn School of Medicine, U.S.A in their recent study revealed that stem cells extracted from placenta also known as Cdx2 cells might be able to regenerate heart cells after the heart attack. From the beginning, it has been thought that Cdx2 cells could only ge...
Read More...
May 27, 2019
The U.S. FDA recently approved the much talked about Novartis’s drug Zolgensma for treating a life-threatening condition Spinal Muscular Atrophy (SMA). SMA is a neuromuscular disorder that worsens the muscles over time. It happens due to a mutation in the SMN1 gene that results in the deficiency of an SMN protein,...
Read More...
Sep 04, 2024
If you’ve been keeping up with our previous posts, you already have a solid understanding of nonalcoholic steatohepatitis (NASH) and its impact. We’ve previously examined the dominance of off-label therapies in the NASH therapeutics market and the challenges associated with this approach. In this post, we’ll take a...
Read More...
May 23, 2019
Merck decides to acquire Peloton Therapeutics, fortifying Oncology pipeline Merck is ready to buy Peloton Therapeutics for USD 1.1 million. The companies have entered into a definitive agreement which will give Merck rights over an oral HIF-2α inhibitor- PT2977, which is Peloton’s lead candidate for the treatme...
Read More...
May 22, 2019
NASH market share of off label therapies, it will keep on experiencing a steady growth until a standard approved therapy enters the NASH treatment market. Non-alcoholic fatty liver disease (NAFLD), is the most common group of conditions in which there is an excess fat accumulation in the liver in people who i...
Read More...
May 30, 2019
Multiple Sclerosis Multiple Sclerosis is an unpredictable, autoimmune disease that affects the central nervous system. In this disease, the body's own immune system produces cells and proteins (antibodies), which attack the fatty substance,myelin that protects the nerve fibres. So, 30 May 2019 is globally obser...
Read More...